| Will complement inhibition be the new target in treating COVID-19–related systemic thrombosis? CM Campbell, R Kahwash Circulation 141 (22), 1739-1741, 2020 | 307 | 2020 |
| Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients … T Feldman, L Mauri, R Kahwash, S Litwin, MJ Ricciardi, P Van Der Harst, ... Circulation 137 (4), 364-375, 2018 | 250 | 2018 |
| A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation WT Abraham, KH Kuck, RL Goldsmith, JA Lindenfeld, VY Reddy, ... Heart Failure 6 (10), 874-883, 2018 | 222 | 2018 |
| One-year safety and clinical outcomes of a transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction in the reduce elevated … SJ Shah, T Feldman, MJ Ricciardi, R Kahwash, S Lilly, S Litwin, ... JAMA cardiology 3 (10), 968-977, 2018 | 144 | 2018 |
| Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial SJ Shah, BA Borlaug, ES Chung, DE Cutlip, P Debonnaire, PS Fail, ... The Lancet 399 (10330), 1130-1140, 2022 | 142 | 2022 |
| Echocardiography and heart failure: a glimpse of the right heart A Pleister, R Kahwash, G Haas, S Ghio, A Cittadini, RR Baliga Echocardiography 32, S95-S107, 2015 | 38 | 2015 |
| Role of the pulmonary artery catheter in diagnosis and management of heart failure R Kahwash, CV Leier, L Miller Heart failure clinics 5 (2), 241-248, 2009 | 38 | 2009 |
| Pilot randomized controlled trial to reduce readmission for heart failure using novel tablet and nurse practitioner education K Breathett, S Maffett, RE Foraker, R Sturdivant, K Moon, A Hasan, ... The American journal of medicine 131 (8), 974-978, 2018 | 37 | 2018 |
| Investigators and Study Coordinators. Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF I [Reduce … T Feldman, L Mauri, R Kahwash, S Litwin, MJ Ricciardi, P van der Harst, ... Circulation 137 (4), 364-375, 2018 | 24 | 2018 |
| Optimizer Smart in the treatment of moderate-to-severe chronic heart failure CM Campbell, R Kahwash, WT Abraham Future Cardiology 16 (1), 13-25, 2019 | 23 | 2019 |
| Assessment of predictors of left atrial volume response to a transcatheter interatrial shunt device (from the REDUCE LAP-HF Trial) TC Hanff, DM Kaye, CS Hayward, MC Post, F Malek, G Hasenfuβ, ... The American journal of cardiology 124 (12), 1912-1917, 2019 | 22 | 2019 |
| REDUCE LAP-HF I Investigators and Study Coordinators. Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF … T Feldman, L Mauri, R Kahwash, S Litwin, MJ Ricciardi, P van der Harst, ... Circulation 137 (4), 364-375, 2018 | 20 | 2018 |
| Recognition and management of sleep-disordered breathing in chronic heart failure R Kahwash, D Kikta, R Khayat Current heart failure reports 8 (1), 72-79, 2011 | 20 | 2011 |
| Cardiac contractility modulation in patients with advanced heart failure R Kahwash, D Burkhoff, WT Abraham Expert Review of Cardiovascular Therapy 11 (5), 635-645, 2013 | 17 | 2013 |
| REDUCE LAP-HF II investigators. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded … SJ Shah, BA Borlaug, ES Chung, DE Cutlip, P Debonnaire, PS Fail, ... Lancet 399 (10330), 1130-1140, 2022 | 16 | 2022 |
| C1 esterase inhibition: targeting multiple systems in COVID-19 TMA Adesanya, CM Campbell, L Cheng, PU Ogbogu, R Kahwash Journal of Clinical Immunology 41, 729-732, 2021 | 15 | 2021 |
| AL amyloidosis: the effect of fluorescent in situ hybridization abnormalities on organ involvement and survival M Ozga, Q Zhao, D Benson Jr, P Elder, N Williams, N Bumma, A Rosko, ... Cancer Medicine 10 (3), 965-973, 2021 | 14 | 2021 |
| A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation. JACC Heart Fail 6 (10): 874–883 WT Abraham, KH Kuck, RL Goldsmith, J Lindenfeld, VY Reddy, ... | 12 | 2018 |
| Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways S Rajpal, R Kahwash, MS Tong, K Paschke, AA Satoskar, B Foreman, ... Journal of the American College of Cardiology 79 (21), 2144-2152, 2022 | 9 | 2022 |
| Left atrial to coronary sinus shunting for treatment of symptomatic heart failure B Hibbert, F Zahr, T Simard, M Labinaz, B Nazer, P Sorajja, P Eckman, ... JACC: Cardiovascular Interventions 16 (11), 1369-1380, 2023 | 8 | 2023 |
